Related Experiment Video

Updated: Sep 10, 2025

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
09:59

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Published on: March 9, 2015

12.3K

The Use of Small Molecules to Correct Defects in CFTR Folding, Maturation, and Channel Activity

Meredith F N Rosser1, Diane E Grove1, Douglas M Cyr1

  • 1Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Current Chemical Biology
|August 22, 2025
PubMed

Insights

Cystic Fibrosis (CF) is caused by CFTR gene mutations affecting protein folding, trafficking, and function. Research focuses on small molecules to correct these defects and restore CFTR channel activity for CF treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Cystic Fibrosis (CF) is a common lethal inherited disease in Caucasians.
  • It results from mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene.
  • CFTR protein functions as a gated chloride channel crucial for epithelial cell hydration.

Purpose of the Study:

  • To review current knowledge on CFTR protein defects caused by mutations.
  • To discuss cellular mechanisms monitoring these defects.
  • To outline strategies for developing small molecule therapeutics for CF.

Main Methods:

  • Review of existing literature on CFTR protein biogenesis and function.
  • Analysis of cellular pathways involved in CFTR quality control.
  • Examination of small molecule screening and development approaches.

Main Results:

  • CFTR mutations impact protein folding, trafficking, and channel gating.
  • Cells possess surveillance mechanisms to monitor CFTR protein integrity.
  • Small molecules show potential for correcting CFTR defects and enhancing channel activity.

Conclusions:

  • Targeting CFTR folding, trafficking, and gating defects with small molecules is a promising therapeutic strategy for Cystic Fibrosis.
  • Understanding cellular monitoring of CFTR is key to developing effective treatments.
  • Continued research in small molecule therapeutics offers hope for CF patients.
Keywords:
Cystic fibrosisER Quality controlchaperonescorrectorspotentiators

More Related Videos

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

14.6K
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

19.4K

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
223
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
360
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
18.4K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
83